Premium Nahrungsergänzungsmittel | artgerecht

Chylothorax – Causes, Symptoms and Treatment

Chylothorax is an accumulation of lymphatic fluid (chyle) in the chest cavity. It is usually caused by injury or disease affecting the thoracic duct and requires prompt medical attention.

Regular tips about health Regular tips about health

Things worth knowing about "Chylothorax"

Chylothorax is an accumulation of lymphatic fluid (chyle) in the chest cavity. It is usually caused by injury or disease affecting the thoracic duct and requires prompt medical attention.

What Is Chylothorax?

Chylothorax is a condition in which chyle – a milky-white lymphatic fluid rich in fats and lymphocytes – accumulates in the pleural space, the area between the lungs and the chest wall. Chyle originates from the thoracic duct, the largest lymphatic vessel in the body, which carries lymph from the digestive system and lower body parts. Chylothorax is a rare but potentially serious condition that requires careful diagnosis and targeted treatment.

Causes

The causes of chylothorax are broadly divided into two categories:

Traumatic Chylothorax

Thoracic surgery (e.g., cardiac surgery, esophageal surgery, lung resection) is the most common cause
Blunt or penetrating chest trauma
Neck procedures or central venous catheter placement causing vessel injury

Non-Traumatic Chylothorax

Malignancies, especially lymphomas (e.g., Hodgkin lymphoma, non-Hodgkin lymphoma) that compress or invade the thoracic duct
Inflammatory conditions such as sarcoidosis or tuberculosis
Lymphangiomatosis and congenital malformations of the lymphatic system
Liver cirrhosis and other conditions causing elevated lymphatic flow
Idiopathic chylothorax (no identifiable cause)

Symptoms

Symptoms depend on the volume of accumulated fluid and the rate at which it collects:

Dyspnea (shortness of breath), often the first symptom to appear
Cough and chest tightness
Reduced breath sounds on the affected side
Tachycardia (rapid heart rate)
Malnutrition and immune suppression in persistent chylothorax, due to ongoing loss of fats, proteins, and lymphocytes
Weight loss and general weakness in chronic cases

Diagnosis

Diagnosis is established through a combination of the following investigations:

Imaging: Chest X-ray or CT scan to detect the pleural effusion
Thoracentesis (pleural tap): Aspiration of pleural fluid for analysis – chyle appears milky-white and shows elevated triglyceride levels (>110 mg/dl) with a predominance of lymphocytes
Lymphoscintigraphy or lymphangiography: To localize the site of lymphatic leakage
MRI or PET-CT to identify underlying malignancy if suspected

Treatment

Treatment depends on the underlying cause and the severity of the condition:

Conservative Management

Dietary modification: A low-fat diet supplemented with medium-chain triglycerides (MCT fats), which are absorbed directly via the portal vein rather than the lymphatic system, thereby reducing lymph flow
Total parenteral nutrition (TPN): Complete intravenous nutrition to give the thoracic duct full rest
Medications: Somatostatin or its analogue octreotide to reduce lymphatic flow
Pleural drainage via chest tube to relieve fluid accumulation

Surgical and Interventional Treatment

Thoracic duct ligation: Surgical closure of the lymphatic vessel, typically performed via video-assisted thoracoscopic surgery (VATS)
Pleurodesis: Chemical or mechanical adhesion of the pleural layers to prevent further fluid accumulation
Lymphatic embolization: An interventional radiology procedure to seal the point of leakage

Treatment of the Underlying Condition

In malignant chylothorax, treating the underlying tumor with chemotherapy or radiation therapy is the primary approach.

Complications

Untreated or prolonged chylothorax can lead to serious complications including malnutrition, immunodeficiency due to lymphocyte loss, electrolyte imbalances, and respiratory failure. Early diagnosis and prompt treatment are therefore essential.

References

McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respiratory Medicine. 2010;104(1):1-8.
Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. European Journal of Cardio-Thoracic Surgery. 2007;32(2):362-369.
Doerr CH, Allen MS, Nichols FC, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clinic Proceedings. 2005;80(7):867-870.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category